(Q29618825)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510162

30 April 2017

author name string

Turner N

series ordinal

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510162

30 April 2017

Tutt A

series ordinal

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510162

30 April 2017

Ashworth A

series ordinal

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510162

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510162

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

October 2004

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510162

30 April 2017

published in

Nature Reviews Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510162

30 April 2017

volume

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510162

30 April 2017

page(s)

814-9

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510162

30 April 2017

issue

10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510162

Cancer susceptibility and the functions of BRCA1 and BRCA2

30 April 2017

cites work

1 reference

The Fanconi anaemia/BRCA pathway

1 May 2017

1 reference

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 May 2017

1 reference

Molecular portraits of human breast tumours

1 May 2017

1 reference

Gene expression profiling predicts clinical outcome of breast cancer

1 May 2017

1 reference

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 May 2017

1 reference

1 May 2017

The Hallmarks of Cancer

1 reference

Worms gang up on bacteria

1 May 2017

1 reference

Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival

1 May 2017

1 reference

A census of human cancer genes

1 May 2017

1 reference

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors

1 May 2017

1 reference

EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer

1 May 2017

1 reference

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

1 May 2017

1 reference

Biallelic inactivation of BRCA2 in Fanconi anemia

1 May 2017

1 reference

A novel ubiquitin ligase is deficient in Fanconi anemia

1 May 2017

1 reference

Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway

1 May 2017

1 reference

Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways

1 May 2017

1 reference

Breast and ovarian cancer

1 May 2017

1 reference

The relationship between the roles of BRCA genes in DNA repair and cancer predisposition

31 March 2020

1 reference

Tracing the network connecting BRCA and Fanconi anaemia proteins

31 March 2020

1 reference

Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

31 March 2020

1 reference

BRCA1 mutations in primary breast and ovarian carcinomas.

31 March 2020

1 reference

BRCA2 mutations in primary breast and ovarian cancers

31 March 2020

1 reference

Stem cells and breast cancer: A field in transit

31 March 2020

1 reference

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

31 March 2020

1 reference

Gene-Expression Profiles in Hereditary Breast Cancer

31 March 2020

1 reference

Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers

31 March 2020

1 reference

Profiling familial breast cancer

31 March 2020

1 reference

p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

31 March 2020

1 reference

The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis.

31 March 2020

1 reference

The fundamental role of epigenetic events in cancer

31 March 2020

1 reference

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

31 March 2020

1 reference

Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens

31 March 2020

1 reference

Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics

31 March 2020

1 reference

Frequency of BRCA1 dysfunction in ovarian cancer

31 March 2020

1 reference

Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer

31 March 2020

1 reference

Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer

31 March 2020

1 reference

Altered methylation patterns in cancer cell genomes: cause or consequence?

31 March 2020

1 reference

MYC is amplified in BRCA1-associated breast cancers.

31 March 2020

1 reference

Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region

31 March 2020

1 reference

Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions

31 March 2020

1 reference

Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer

31 March 2020

1 reference

A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining.

31 March 2020

1 reference

Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers

31 March 2020

1 reference

Inactivation of BRCA1 and BRCA2 in ovarian cancer

31 March 2020

1 reference

Familial invasive breast cancers: worse outcome related to BRCA1 mutations

31 March 2020

1 reference

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

31 March 2020

1 reference

Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma.

31 March 2020

1 reference

Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions

31 March 2020

1 reference

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells

31 March 2020

1 reference

Choices--and uncertainties--for women with BRCA mutations

31 March 2020

1 reference

Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway

31 March 2020

1 reference

Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance.

31 March 2020

1 reference

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

31 March 2020

1 reference

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

31 March 2020

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510162

31 March 2020

Identifiers

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1052616

1042257134

0 references

1052616

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15510162

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017